Market Insights Health OTC Pharmaceuticals

Cold & Cough Remedies - Netherlands

Netherlands

In the country in the Netherlands, the revenue in the Cold & Cough Remedies market market reaches a total of US$235.80m in 2024.
It is projected that the market will experience an annual growth rate of 4.14% (CAGR 2024-2029).
When compared to other countries worldwide, the in the United States generates the highest revenue in this market, amounting to US$11,190.00m in 2024.
Taking into account the total population figures, the per person revenue in the Netherlands in 2024 is US$13.35.
Despite a growing trend towards natural remedies, the Netherlands continues to see a strong demand for over-the-counter cold and cough remedies.

Key regions: Australia, Japan, India, Brazil, Canada

Market

Region

Region comparison

Currency

Analyst Opinion

The Cold & Cough Remedies market in Netherlands has been experiencing steady growth in recent years.

Customer preferences: Customers in Netherlands have shown a growing interest in natural and herbal remedies for cold and cough. They are increasingly seeking products that are made from natural ingredients and have minimal side effects. This preference for natural remedies is driven by a desire for healthier and more sustainable options. In addition, customers are also looking for products that provide quick relief from symptoms and are easy to use. Convenience and effectiveness are key factors that influence customer preferences in the Cold & Cough Remedies market in Netherlands.

Trends in the market: One of the key trends in the Cold & Cough Remedies market in Netherlands is the rising demand for over-the-counter (OTC) products. Customers are increasingly opting for self-medication and are looking for OTC products that are easily accessible and affordable. This trend is driven by the convenience and cost-effectiveness of OTC products compared to prescription medications. In addition, the availability of a wide range of OTC products in pharmacies and supermarkets has also contributed to the growth of this segment.Another trend in the market is the increasing popularity of combination products. Customers are looking for products that provide relief from multiple symptoms, such as congestion, cough, and sore throat, in a single formulation. Combination products offer convenience and save customers the hassle of purchasing multiple products for different symptoms. This trend is driven by the busy lifestyles of customers who are looking for quick and effective solutions to their cold and cough symptoms.

Local special circumstances: The Cold & Cough Remedies market in Netherlands is influenced by the country's healthcare system, which emphasizes self-care and self-medication. The Dutch healthcare system encourages individuals to take responsibility for their own health and provides easy access to OTC products. This has created a favorable environment for the growth of the Cold & Cough Remedies market in Netherlands.

Underlying macroeconomic factors: The growth of the Cold & Cough Remedies market in Netherlands is also influenced by macroeconomic factors such as disposable income and healthcare expenditure. As disposable income increases, customers have more purchasing power and are willing to spend on healthcare products. In addition, the government's focus on healthcare and wellness has led to increased healthcare expenditure, which has further fueled the growth of the Cold & Cough Remedies market in Netherlands.Overall, the Cold & Cough Remedies market in Netherlands is driven by customer preferences for natural and convenient products, the increasing popularity of OTC products, and the country's healthcare system that promotes self-care and self-medication. These factors, along with underlying macroeconomic factors, are contributing to the steady growth of the market in Netherlands.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.